These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17933117)

  • 21. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.
    Loren AW; Porter DL
    Bone Marrow Transplant; 2008 Mar; 41(5):483-93. PubMed ID: 18026156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells.
    Berry LJ; Moeller M; Darcy PK
    Tissue Antigens; 2009 Oct; 74(4):277-89. PubMed ID: 19775368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
    Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA
    Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive T-cell therapy for malignant disorders.
    Powell DJ; Levine BL
    Haematologica; 2008 Oct; 93(10):1452-6. PubMed ID: 18827263
    [No Abstract]   [Full Text] [Related]  

  • 25. Translational research in melanoma.
    Tsai S; Sabel MS
    Surg Oncol Clin N Am; 2008 Apr; 17(2):391-419, ix-x. PubMed ID: 18375359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.
    Kakimi K; Nakajima J; Wada H
    Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose chemotherapy and adoptive immunotherapy in the treatment of recurrent pediatric brain tumors.
    Peres E; Wood GW; Poulik J; Baynes R; Sood S; Abidi MH; Klein J; Bhambhani K; Dansey R; Abella E
    Neuropediatrics; 2008 Jun; 39(3):151-6. PubMed ID: 18991194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen choice in adoptive T-cell therapy of cancer.
    Offringa R
    Curr Opin Immunol; 2009 Apr; 21(2):190-9. PubMed ID: 19297140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next generation adoptive immunotherapy--human T cells as carriers of therapeutic nanoparticles.
    Mortensen MW; Kahns L; Hansen T; Sorensen PG; Björkdahl O; Jensen MR; Gundersen HJ; Bjørnholm T
    J Nanosci Nanotechnol; 2007 Dec; 7(12):4575-80. PubMed ID: 18283847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of hematological malignancy-associated antigens and clinical applications.
    Fujiwara H
    Rinsho Ketsueki; 2009 May; 50(5):340-51. PubMed ID: 19483393
    [No Abstract]   [Full Text] [Related]  

  • 31. Collection of large-scale expanded lymphocyte cultures for adoptive immunotherapy using a COBE Spectra apheresis machine.
    Schallmach E; Sareli R; Besser MJ; Leipsiger S; Hardan I; Treves AJ; Nagler A; Schachter J
    J Immunother; 2008; 31(6):563-8. PubMed ID: 18528298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular domain of 4-1BBL enhanced the antitumoral efficacy of peripheral blood lymphocytes mediated by anti-CD3 x anti-Pgp bispecific diabody against human multidrug-resistant leukemia.
    Guo H; Jiang W; Liu W; Gao Y; Yang M; Zhou Y; Wang J; Qi J; Cheng X; Zhu Z; Yang C; Xiong D
    Cell Immunol; 2008 Feb; 251(2):102-8. PubMed ID: 18482719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy combined with chemotherapy in the treatment of tumors.
    Frazier JL; Han JE; Lim M; Olivi A
    Neurosurg Clin N Am; 2010 Jan; 21(1):187-94. PubMed ID: 19944977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells.
    Zhong RK; Lane TA; Ball ED
    Exp Hematol; 2008 Apr; 36(4):486-94. PubMed ID: 18249062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of melanoma reactive T cell by using a monocyte-based solid phase T-cell selection system for adoptive therapy.
    Li J; Mookerjee B; Wagner J
    J Immunother; 2008 Jan; 31(1):81-8. PubMed ID: 18157015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation].
    Hudecek M; Bartsch K; Tschiedel S; Niederwieser D
    Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1511-6. PubMed ID: 18597211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma.
    Har-Noy M; Zeira M; Weiss L; Fingerut E; Or R; Slavin S
    Leuk Res; 2009 Apr; 33(4):525-38. PubMed ID: 18834631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy.
    Willemsen R; Chames P; Schooten E; Gratama JW; Debets R
    Cytometry A; 2008 Nov; 73(11):1093-9. PubMed ID: 18785268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adoptive cellular immunotherapy for viral diseases.
    Fujita Y; Rooney CM; Heslop HE
    Bone Marrow Transplant; 2008 Jan; 41(2):193-8. PubMed ID: 17982497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell death in hematological tumors.
    Fulda S
    Apoptosis; 2009 Apr; 14(4):409-23. PubMed ID: 19130230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.